DrugBank 5.0: a major update to the DrugBank database for 2018
Explore this paper's citation graph
Summary
This year’s update, DrugBank 5.0, represents the most significant upgrade to the database in more than 10 years and significant improvements have been made to the quantity, quality and consistency of drug indications, drug binding data as well as drug-drug and drug-food interactions.
- Type
- article
- Published
- 2017-11-08
- Cited by
- 7,469
- References
- 22
- Access
- Open access
- OpenAlex
- https://openalex.org/W2767891136
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:29807737
Keywords
DrugBank, Drug repositioning, Drug, Database, Biology
References
- Metabolomic Signatures for Drug Response Phenotypes-Pharmacometabolomics Enables Precision Medicine
- Pathways with PathWhiz
- PolySearch2: a significantly improved text-mining system for discovering associations between human diseases, genes, drugs, metabolites, toxins and more
- DrugBank: a knowledgebase for drugs, drug actions and drug targets
- DrugBank 4.0: shedding new light on drug metabolism
- Pharmacogenomics: a systems approach
- Predicting drug metabolism: experiment and/or computation?
- CFM-ID: a web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra
- DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs
- The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects
- DrugBank: a comprehensive resource for in silico drug discovery and exploration
- Adverse drug reactions in the elderly
- Computational Prediction of Electron Ionization Mass Spectra to Assist in GC/MS Compound Identification.
- Using DrugBank for In Silico Drug Exploration and Discovery
- Precision medicine: from pharmacogenomics to pharmacoproteomics
- ClassyFire: automated chemical classification with a comprehensive, computable taxonomy
- SPLASH, A hashed identifier for mass spectra
- The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)
- nmrML: A Community Supported Open Data Standard for the Description, Storage, and Exchange of NMR Data.
- CHEMINFORMATICS TOOLS FOR ENABLING METABOLOMICS
Cited by
- Identification of FDA-approved drugs as novel allosteric inhibitors of human executioner caspases
- Paradigm Shift in Drug Re-purposing From Phenalenone to Phenaleno-Furanone to Combat Multi-Drug Resistant Salmonella enterica Serovar Typhi
- PathwayMap: Molecular Pathway Association with Self-Normalizing Neural Networks
- Prediction of drug-disease associations based on ensemble meta paths and singular value decomposition
- Regulation of antibody-mediated complement-dependent cytotoxicity by modulating the intrinsic affinity and binding valency of IgG for target antigen
- In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
- The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers
- Effect of Cysteine Oxidation in SARS-CoV-2 Receptor-Binding Domain on Its Interaction with Two Cell Receptors: Insights from Atomistic Simulations
- Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics: a Mendelian randomization study and colocalization analysis
- Cisplatine : une vieille molécule pour de nouveaux défis. : développement d’une prodrogue macromoléculaire multifonctionnelle applicable au traitement local du glioblastome
- Pd-Catalyzed C-H aziridination of 3,3,5,5-tetrasubstituted piperazin-2-ones.
- Evaluation of sulfamethazine removal kinetics using fixed structured bed bioreactor
- The hitchhiker's guide to the chemical-biological galaxy.
- Design of a tripartite network for the prediction of drug targets
- Molecular map of GNAO1-related disease phenotypes and reactions to therapy
- The effect of adding radiotherapy to the administrated chemotherapy on infants' gut microbiome
- A genome-wide association study for shared risk across major psychiatric disorders in a nation-wide birth cohort implicates fetal neurodevelopment as a key mediator
- A desirability-based multi objective approach for the virtual screening discovery of broad-spectrum anti-gastric cancer agents
- Unexplored therapeutic opportunities in the human genome
- Media pH and media type can significantly affect the reliability of in vitro copper tolerance assessments of Pseudomonas syringae pv. tomato
Related papers
- Drug and Protein Interaction Network Construction for Drug Repurposing in Alzheimer’s Disease
- Network-based drug repurposing for HPV-associated cervical cancer
- Tumor relapse-free survival prognosis related consistency between cancer tissue and adjacent normal tissue in drug repurposing for solid tumor via connectivity map
- Bioinformatics and systems biology analysis revealed PMID26394986-Compound-10 as potential repurposable drug against covid-19
- Combined in silico strategy for repurposing DrugBank entries towards introducing potential antiSARS-CoV-2 drugs.
- Drug Repurposing Based on Drug–Drug Interaction
- Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach
- Drug Repurposing Using Modularity Clustering in Drug-Drug Similarity Networks Based on Drug–Gene Interactions